ES8106838A1 - Aparato de inhalacion - Google Patents

Aparato de inhalacion

Info

Publication number
ES8106838A1
ES8106838A1 ES497524A ES497524A ES8106838A1 ES 8106838 A1 ES8106838 A1 ES 8106838A1 ES 497524 A ES497524 A ES 497524A ES 497524 A ES497524 A ES 497524A ES 8106838 A1 ES8106838 A1 ES 8106838A1
Authority
ES
Spain
Prior art keywords
capsule
sleeve
chamber
body shell
retaining means
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES497524A
Other languages
English (en)
Spanish (es)
Other versions
ES497524A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ES497524A0 publication Critical patent/ES497524A0/es
Publication of ES8106838A1 publication Critical patent/ES8106838A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
ES497524A 1979-12-06 1980-12-05 Aparato de inhalacion Expired ES8106838A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7942208 1979-12-06

Publications (2)

Publication Number Publication Date
ES497524A0 ES497524A0 (es) 1981-09-16
ES8106838A1 true ES8106838A1 (es) 1981-09-16

Family

ID=10509680

Family Applications (1)

Application Number Title Priority Date Filing Date
ES497524A Expired ES8106838A1 (es) 1979-12-06 1980-12-05 Aparato de inhalacion

Country Status (31)

Country Link
US (1) US4353365A (enExample)
JP (1) JPS5691752A (enExample)
AR (1) AR227898A1 (enExample)
AT (1) AT390375B (enExample)
AU (1) AU537918B2 (enExample)
BE (1) BE886531A (enExample)
BR (1) BR8007911A (enExample)
CA (1) CA1115614A (enExample)
CH (1) CH646064A5 (enExample)
DE (1) DE3046108A1 (enExample)
DK (1) DK153631C (enExample)
ES (1) ES8106838A1 (enExample)
FI (1) FI71487C (enExample)
FR (1) FR2473319B1 (enExample)
GR (1) GR69899B (enExample)
HK (1) HK83285A (enExample)
IE (1) IE50581B1 (enExample)
IL (1) IL61639A (enExample)
IN (1) IN154870B (enExample)
IT (1) IT1148238B (enExample)
KE (1) KE3565A (enExample)
MY (1) MY8500735A (enExample)
NL (1) NL187193C (enExample)
NO (1) NO148770C (enExample)
NZ (1) NZ195766A (enExample)
PH (1) PH17193A (enExample)
PT (1) PT72164B (enExample)
SE (1) SE431163B (enExample)
SG (1) SG71985G (enExample)
YU (1) YU309180A (enExample)
ZA (1) ZA807639B (enExample)

Families Citing this family (126)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES286422Y (es) * 1982-10-08 1986-09-16 Glaxo Group Limited Dispositivo para administrar medicamentos a pacientes
USD295787S (en) 1985-05-13 1988-05-17 Hegemann Manfred K Nasal spray dispenser
SE453566B (sv) * 1986-03-07 1988-02-15 Draco Ab Anordning vid pulverinhalatorer
US4706663A (en) * 1986-04-25 1987-11-17 Makiej Paul A Particle catcher for inhalation devices
JPS63143081A (ja) * 1986-12-05 1988-06-15 メクト株式会社 吸入器
US5011044A (en) * 1987-07-02 1991-04-30 Brown Arlon R Anti-assault device
DE8714078U1 (de) * 1987-10-21 1988-02-04 Schott, Käte, 8651 Kupferberg Mediokugel für Babyschnuller
US5239991A (en) * 1989-06-21 1993-08-31 Fisons Plc Disposable powder medicament inhalation device with peel-off cover
MY105368A (en) * 1990-03-02 1994-09-30 Glaxo Group Ltd Inhalation device.
US5492112A (en) * 1991-05-20 1996-02-20 Dura Pharmaceuticals, Inc. Dry powder inhaler
US5161524A (en) * 1991-08-02 1992-11-10 Glaxo Inc. Dosage inhalator with air flow velocity regulating means
US5301664A (en) * 1992-03-06 1994-04-12 Sievers Robert E Methods and apparatus for drug delivery using supercritical solutions
AU684754B2 (en) * 1993-03-03 1998-01-08 Glaxo Wellcome Inc. Dry powder inhalator medicament carrier
US5388572A (en) * 1993-10-26 1995-02-14 Tenax Corporation (A Connecticut Corp.) Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en) * 1993-12-02 1995-02-14 Tenax Corporation Dry powder inhalator medicament carrier
SK282460B6 (sk) * 1994-10-04 2002-02-05 The Procter And Gamble Company Zariadenie na rozprašovanie časticového materiálu a spôsob rozprašovania časticového materiálu
US5669378A (en) * 1995-12-21 1997-09-23 Pera; Ivo Inhaling device
US5699789A (en) * 1996-03-11 1997-12-23 Hendricks; Mark R. Dry powder inhaler
US5871010A (en) * 1996-06-10 1999-02-16 Sarnoff Corporation Inhaler apparatus with modified surfaces for enhanced release of dry powders
US5857456A (en) * 1996-06-10 1999-01-12 Sarnoff Corporation Inhaler apparatus with an electronic means for enhanced release of dry powders
DE19835346A1 (de) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
US6451289B2 (en) 2000-03-24 2002-09-17 Sepracor Inc. Albuterol formulations
US6596262B2 (en) 2001-02-15 2003-07-22 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
US6485707B2 (en) 2001-02-15 2002-11-26 Aeropharm Technology Incorporated Modulated release particles for aerosol delivery
EP1238680B1 (en) * 2001-03-05 2003-12-10 Ivo Pera Inhaling device for dispersing powdered medicaments contained in a capsule through the respiratory tract
US6681768B2 (en) 2001-06-22 2004-01-27 Sofotec Gmbh & Co. Kg Powder formulation disintegrating system and method for dry powder inhalers
GB2380410B (en) * 2001-10-05 2003-11-19 Alchemy Healthcare Ltd Apparatus for the nasal or oral delivery of a medicament
GB0208609D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Compositions
GB0208608D0 (en) * 2002-04-13 2002-05-22 Glaxo Group Ltd Composition
EP1587482A4 (en) * 2003-01-31 2010-08-25 Technion Res & Dev Foundation INFLAMMATORY COMPOSITIONS AND ITS USES
PE20040950A1 (es) 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
TW200510298A (en) 2003-06-13 2005-03-16 Theravance Inc Substituted pyrrolidine and related compounds
GB0316335D0 (en) * 2003-07-11 2003-08-13 Glaxo Group Ltd Pharmaceutical formulations
GB0324654D0 (en) * 2003-10-22 2003-11-26 Glaxo Group Ltd Medicinal compounds
GB0324886D0 (en) * 2003-10-24 2003-11-26 Glaxo Group Ltd Medicinal compounds
GB0324897D0 (en) * 2003-10-24 2003-11-26 Glaxo Group Ltd Composition
GB0329182D0 (en) * 2003-12-17 2004-01-21 Glaxo Group Ltd Chemical compounds
US7624733B2 (en) * 2004-02-09 2009-12-01 Oriel Therapeutics, Inc. Inhalers with extendable/retractable forward member and associated methods of dispensing inhalant substances
TWI341836B (en) 2004-03-11 2011-05-11 Theravance Inc Biphenyl compounds useful as muscarinic receptor antagonists
US20060120972A1 (en) * 2004-11-09 2006-06-08 Peter Engels 9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension
DE102005001332A1 (de) * 2005-01-11 2006-07-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Zweiteilige Kapsel mit Vorverschluss zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
DK1901749T3 (en) 2005-05-18 2016-10-24 Raptor Pharmaceuticals Inc Aerosolized fluoroquinolones AND USES THEREOF
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
EP1844805A1 (de) * 2006-04-13 2007-10-17 Boehringer Ingelheim Pharma GmbH & Co.KG Inhalator
AU315526S (en) 2006-09-28 2007-08-03 Glaxo Group Ltd Inhalation device
EP3272379A1 (en) 2008-02-07 2018-01-24 The University of Washington Circumferential aerosol device
CN103190631B (zh) 2008-03-20 2016-01-20 维尔恩公司 非水性预乳液组合物及制备包含植物甾醇的饮料的方法
AU2009226019C1 (en) 2008-03-20 2014-02-20 Virun, Inc. Emulsions including a PEG-derivative of tocopherol
US8337931B2 (en) * 2008-06-23 2012-12-25 Virun, Inc. Compositions containing non-polar compounds
CA2739893C (en) 2008-10-07 2016-10-04 Mpex Pharmaceuticals, Inc. Inhalation of levofloxacin for reducing lung inflammation
US8815838B2 (en) 2008-10-07 2014-08-26 David C. Griffith Aerosol fluoroquinolone formulations for improved pharmacokinetics
CN104523661A (zh) 2009-02-06 2015-04-22 南加利福尼亚大学 含有单萜的治疗组合物
PL2987490T3 (pl) 2009-07-15 2017-12-29 Theravance Biopharma R&D Ip, Llc Postacie krystaliczne wolnej zasady związku bifenylowego
EP3569235A1 (en) 2009-09-04 2019-11-20 Horizon Orphan LLC Use of aerosolized levofloxacin for treating cystic fibrosis
CN102573886A (zh) * 2009-09-17 2012-07-11 相互制药公司 用抗病毒剂治疗哮喘的方法
CA2779488A1 (en) 2009-11-12 2011-05-19 Stc.Unm Dry powder inhaler with flutter dispersion member
US10210216B2 (en) * 2009-12-18 2019-02-19 Sybase, Inc. Dynamic attributes for mobile business objects
US8507734B2 (en) 2010-03-03 2013-08-13 Neonc Technologies Inc. Pharmaceutical compositions comprising monoterpenes
CN103037708B (zh) 2010-03-23 2015-05-20 维尔恩公司 含有蔗糖脂肪酸酯的纳米乳液
WO2011162802A1 (en) 2010-06-21 2011-12-29 Virun, Inc. Compositions containing non-polar compounds
FR2962342B1 (fr) * 2010-07-07 2013-02-15 Valois Sas Inhalateur de poudre seche.
RU2013105007A (ru) * 2010-07-07 2014-08-20 Аптар Франс Сас Способ применения ингалятора сухого порошка
FR2962343B1 (fr) * 2010-07-07 2012-08-03 Valois Sas Inhalateur de poudre seche.
FR2962340B1 (fr) * 2010-07-07 2012-08-03 Valois Sas Inhalateur de poudre seche.
FR2962337B1 (fr) * 2010-07-07 2013-02-15 Valois Sas Inhalateur de poudre seche.
FR2962341B1 (fr) * 2010-07-07 2013-02-15 Valois Sas Inhalateur de poudre seche.
WO2012083178A1 (en) 2010-12-17 2012-06-21 Neo Oncology Inc. Methods and devices for using isoperillyl alcohol
US9499461B2 (en) 2010-08-27 2016-11-22 Neonc Technologies, Inc. Pharmaceutical compositions comprising POH derivatives
US20160038600A1 (en) 2012-08-03 2016-02-11 Neonc Technologies Inc. Pharmaceutical compositions comprising poh derivatives
USD666492S1 (en) 2010-11-01 2012-09-04 Colgate-Palmolive Company Cap for a container
USD666096S1 (en) 2010-11-01 2012-08-28 Colgate-Palmolive Company Cap for a container
USD666097S1 (en) 2010-11-01 2012-08-28 Colgate-Palmolive Company Cap for a container
USD666493S1 (en) 2010-11-01 2012-09-04 Colgate-Palmolive Company Cap for a container
USD666099S1 (en) 2010-11-01 2012-08-28 Colgate-Palmolive Company Cap for a container
USD666098S1 (en) 2010-11-01 2012-08-28 Colgate-Palmolive Company Cap for a container
JP6050758B2 (ja) 2010-12-07 2016-12-21 レスピラ セラピューティクス インコーポレイテッドＲｅｓｐｉｒａ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 乾燥粉末吸入器及びその作動方法
JP6021117B2 (ja) 2011-01-31 2016-11-02 ジェノア ファーマシューティカルズ，インク． エアロゾルのピルフェニドンおよびピリドンアナログの化合物、および、その使用
CA3111516C (en) 2011-03-03 2023-05-23 Impel Neuropharma, Inc. Nasal drug delivery device
AU2012253569B2 (en) 2011-05-09 2018-02-15 Impel Pharmaceuticals Inc. Nozzles for nasal drug delivery
FR2977498B1 (fr) * 2011-07-05 2015-10-02 Valois Sas Inhalateur de poudre seche.
KR102002187B1 (ko) 2011-07-13 2019-07-19 파맥시스 엘티디 전달 장치에 관한 개선
DK2731571T3 (da) * 2011-07-13 2020-02-17 Pharmaxis Ltd Forbedringer vedrørende leveringsanordninger
WO2013120025A1 (en) 2012-02-10 2013-08-15 Virun, Inc. Beverage compositions containing non-polar compounds
US10463815B2 (en) 2012-02-21 2019-11-05 Respira Therapeutics, Inc. Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agents
US20150343159A1 (en) 2012-07-05 2015-12-03 Glaxo Group Limited Inhaler Device
UA111442C2 (uk) * 2012-10-02 2016-04-25 Кмс Ді Колозіо Мауро Інгаляційний пристрій
US9764103B2 (en) * 2012-10-05 2017-09-19 Lily A. Neff Salt puffer
US9757395B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9757529B2 (en) 2012-12-20 2017-09-12 Otitopic Inc. Dry powder inhaler and methods of use
US9351517B2 (en) 2013-03-15 2016-05-31 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and compositions containing same
CA2909954C (en) 2013-04-28 2021-03-23 Impel Neuropharma, Inc. Medical unit dose container
US10149823B2 (en) 2013-04-30 2018-12-11 Otitopic Inc. Dry powder formulations and methods of use
US20150044288A1 (en) 2013-07-31 2015-02-12 Windward Pharma, Inc. Aerosol tyrosine kinase inhibitor compounds and uses thereof
US9693574B2 (en) 2013-08-08 2017-07-04 Virun, Inc. Compositions containing water-soluble derivatives of vitamin E mixtures and modified food starch
EP4491180A1 (en) 2014-01-10 2025-01-15 Avalyn Pharma Inc. Aerosol pirfenidone and pyridone analog compounds and uses thereof
DK3107548T3 (da) 2014-02-20 2022-07-18 Otitopic Inc Tørpulverformuleringer til inhalation
US10016363B2 (en) 2014-09-18 2018-07-10 Virun, Inc. Pre-spray emulsions and powders containing non-polar compounds
US9861611B2 (en) 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
CA2965759C (en) 2014-10-31 2023-12-12 Glaxosmithkline Intellectual Property Development Limited Powdered polypeptides with decreased disulfide impurities comprising divalent cationic materials
EP3244952A4 (en) 2015-01-14 2018-11-14 Respira Therapeutics, Inc. Powder dispersion methods and devices
CN107613768B (zh) 2015-02-12 2020-10-20 NeOnc技术股份有限公司 包含紫苏醇衍生物的药物组合物
MX2018002895A (es) 2015-09-10 2018-07-06 Impel Neuropharma Inc Dispositivo de administracion nasal en linea.
BR112018009899A8 (pt) 2015-11-18 2019-02-26 Glaxosmithkline Ip No 2 Ltd composição, inalador, forma de dosagem única, métodos para fabricar partículas, para melhorar as exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para prevenir as exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para reduzir a incidência das exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para reduzir a gravidade das exacerbações induzidas por infecção respiratória de um distúrbio respiratório, para prevenir uma infecção respiratória viral e para fabricar uma partícula de inalação de pó seco de ribavirina controlada na forma polimorfa cristalina, partículas fabricadas, método de tratamento, pluralidade de partículas, e, recipiente de dose.
IT201600095707A1 (it) * 2016-09-23 2018-03-23 Cms Di Colosio Mauro Dispositivo inalatore
IT201600095634A1 (it) * 2016-09-23 2018-03-23 Cms Di Colosio Mauro Dispositivo inalatore
CN110267538B (zh) 2016-11-30 2022-04-19 尼昂克技术公司 紫苏醇-3-溴丙酮酸缀合物和治疗癌症的方法
US9731103B1 (en) 2017-01-13 2017-08-15 Berkshire Biomedical, LLC Computerized oral prescription administration devices and associated systems and methods
RU170809U1 (ru) * 2017-03-01 2017-05-11 федеральное государственное бюджетное образовательное учреждение высшего образования "Нижегородский государственный технический университет им. Р.Е. Алексеева" (НГТУ) Распылитель порошкообразных материалов со сменной насадкой
WO2018174938A1 (en) 2017-03-23 2018-09-27 Virun, Inc. Stable dry powders and emulsions containing probiotics and mucoadhesive protein
US10792226B2 (en) 2017-06-07 2020-10-06 Berkshire Biomedical, LLC Refill and dosage management devices and associated systems and methods for use with computerized oral prescription administration devices
EP3713628A4 (en) 2017-11-21 2021-08-18 Impel Neuropharma Inc. INTRA-NASAL DEVICE WITH DIVER TUBE
CN111372635B (zh) 2017-11-21 2022-08-16 英倍尔制药公司 带有入口接口的鼻内装置
RU2020125871A (ru) 2018-01-05 2022-02-07 Импел Ньюрофарма, Инк. Интраназальная доставка дигидроэрготамина с помощью прецизионного устройства для доставки в обонятельную область
AU2019205329B2 (en) 2018-01-05 2023-04-20 Impel Pharmaceuticals Inc. Intranasal delivery of olanzapine by precision olfactory device
JP7325425B2 (ja) 2018-02-08 2023-08-14 ネオンク テクノロジーズ インク． 血液脳関門を透過性にする方法
US10441509B2 (en) 2018-03-16 2019-10-15 Berkshire Biomedical, LLC Computerized oral prescription administration with refillable medication dispensing devices and associated systems and methods
CN112955134A (zh) 2018-07-19 2021-06-11 英倍尔药业股份有限公司 用于治疗帕金森氏病的左旋多巴和多巴脱羧酶抑制剂的呼吸道递送
CN113473967B (zh) 2019-01-03 2022-09-09 英倍尔制药公司 经鼻药物递送装置
EP3937957A1 (en) 2019-03-14 2022-01-19 OM Pharma SA Process for making stable bacterial extracts and their use as pharmaceuticals
BR112021018086A2 (pt) 2019-03-14 2021-11-23 Univ Arizona Método de tratamento e/ou prevenção de asma, exacerbações de asma, asma alérgica e/ou condições associadas com microbiota relacionadas a distúrbios respiratórios
WO2020236658A1 (en) 2019-05-17 2020-11-26 Impel Neuropharma, Inc. Single-use nasal delivery device
US10729860B1 (en) 2019-05-22 2020-08-04 Berkshire Biomedical, LLC Computerized oral prescription administration for securely dispensing a medication and associated systems and methods
WO2022240897A1 (en) 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung
WO2023028364A1 (en) 2021-08-27 2023-03-02 Sepelo Therapeutics, Llc Targeted compositions and uses therof
JP2025513460A (ja) 2022-04-22 2025-04-24 クエンチ メディカル インコーポレイテッド 粉末吸入による医薬品の送達
WO2023232976A1 (en) 2022-06-03 2023-12-07 Ags Therapeutics Sas Extracellular vesicles from genetically-modified microalgae containing endogenously-loaded cargo, their preparation, and uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1404338A (en) * 1972-08-04 1975-08-28 Beecham Group Ltd Device for the inhalation of medicaments
GB1561835A (en) * 1976-02-11 1980-03-05 Allen & Hanburys Ltd Devices for dispensing medicamtens
GB1598081A (en) * 1977-02-10 1981-09-16 Allen & Hanburys Ltd Inhaler device for dispensing medicaments
IE46865B1 (en) * 1977-04-29 1983-10-19 Allen & Hanburys Ltd Device for dispensing medicaments

Also Published As

Publication number Publication date
AU537918B2 (en) 1984-07-19
SE8008550L (sv) 1981-06-07
BR8007911A (pt) 1981-06-16
IN154870B (enExample) 1984-12-22
FI71487C (fi) 1987-01-19
NL187193B (nl) 1991-02-01
FR2473319A1 (fr) 1981-07-17
IT1148238B (it) 1986-11-26
GR69899B (enExample) 1982-07-20
CH646064A5 (de) 1984-11-15
IL61639A (en) 1983-12-30
AT390375B (de) 1990-04-25
DK522480A (da) 1981-06-07
PT72164A (en) 1981-01-01
DE3046108C2 (enExample) 1990-03-01
HK83285A (en) 1985-11-08
NO803685L (no) 1981-06-09
PH17193A (en) 1984-06-14
NO148770B (no) 1983-09-05
CA1115614A (en) 1982-01-05
ATA595680A (de) 1989-10-15
FI71487B (fi) 1986-10-10
FR2473319B1 (fr) 1986-04-18
PT72164B (en) 1982-07-06
MY8500735A (en) 1985-12-31
DK153631B (da) 1988-08-08
IE802548L (en) 1981-06-06
JPS5691752A (en) 1981-07-24
SE431163B (sv) 1984-01-23
ES497524A0 (es) 1981-09-16
IT8050314A0 (it) 1980-12-05
YU309180A (en) 1983-02-28
DE3046108A1 (de) 1981-08-27
DK153631C (da) 1989-01-02
ZA807639B (en) 1982-08-25
NO148770C (no) 1983-12-14
US4353365A (en) 1982-10-12
SG71985G (en) 1986-05-02
FI803800L (fi) 1981-06-07
KE3565A (en) 1985-11-01
NL187193C (nl) 1991-07-01
JPH0127750B2 (enExample) 1989-05-30
IE50581B1 (en) 1986-05-14
AR227898A1 (es) 1982-12-30
BE886531A (fr) 1981-06-05
AU6512580A (en) 1981-06-18
NZ195766A (en) 1982-05-25
NL8006631A (nl) 1981-07-01

Similar Documents

Publication Publication Date Title
ES8106838A1 (es) Aparato de inhalacion
IE780697L (en) Device for dispensing medicaments
IL111254A0 (en) Powder inhalers
GB1520064A (en) Inhalation device
AU550712B2 (en) Aerosol can medicament oral inhalator
SE7701383L (sv) Organ for utmatning av lekemedel
ES448763A1 (es) Un dispositivo de inhalacion accionado por la respiracion para suministrar un medicamento.
ES245395U (es) Dispositivo de inhalacion con abridor de capsula
GB2064336A (en) Device for dispensing medicaments
ES8206980A1 (es) Un dispositivo para facilitar la inhalacion oral de medica- mentos en forma de polvo
ATE185977T1 (de) Inhalator
ES444239A1 (es) Un dispositivo para inhalacion destinado a administrar un medicamento desde un recipiente que lo contiene.
GB1305172A (enExample)
CA2239292A1 (en) Inhalator designed to provide multiple doses of a dry pharmacological powder
ES444240A1 (es) Un dispositivo para administrar un medicamento en polvo por inhalacion de un usuario.
GB2064334A (en) Inhalation valve for administering powdered medicaments
GB855141A (en) Improvements in or relating to medicated cigarette devices
ES167522U (es) Inhalador bucal.
ES174085U (es) Pipa-boquilla, perfeccionada.
ES257644U (es) Dispositivo inhalador

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010611